CARTANA is a Swedish Biotechnology company that maps gene expression in brain tissue via In Situ Sequencing (ISS), the 4th generation of sequencing technologies.
Our solution enables simultaneous analysis of hundreds of genes within all cells comprising a tissue, without losing tissue morphology, with high sensitivity and throughput in several research areas.
- Revolutionary research and biomarker discovery
- Treatment validation
- Future diagnostic tool
Neuroscience, Immunology, and Oncology.
CARTANA’s Products and Services
Neuro Kit
Select your genes of interest (based on RNAseq or single-cell-RNAseq data) and place an order with CARTANA.
Customized kits based on your selected genes.
Simple protocols.
In Situ Sequencing Service
Results are delivered as a morphological map of gene expression, down to single cell level.
You can scroll through that map, view and compare gene expression of individual cells within different brain regions.
Quick time to result.
Contact us
Receive advice on how CARTANA’s in Situ Sequencing can advance your research.
CARTANA’s Technology
In Situ Sequencing technology comprises
- a new sample & library preparation part,
- a new probe barcoding design,
- a novel sequencing method.
The result is a map of gene expression data of all analyzed genes and their abundance with sub-cellular resolution on top of the natural morphology of the tissue section.
CARTANA’s Partners & Collaborators
Discover The Future
We are a multi-disciplinary laboratory
committed to the advancement of biology.